Health TrialsbyHealthPanel

Emergency Department-Substance Use Screening, Motivational Interviewing and Active Referral Targeting Substance Use Disorder and Overdose Prevention

ConditionSubstance Use (Drugs, Alcohol)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPurdue University

About this trial

The purpose of this research study is to learn if an emergency department screening and telehealth intervention reduces substance use among individuals receiving emergency department treatment at The Ohio State University Wexner Medical Center.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult at least 18 years of age

Capacity and willingness to participate (including reliable phone or internet access for counseling session)

Lower or Moderate Risk score on one or more substance use types on National Institute on Drug Abuse (NIDA)-Modified Alcohol, Smoking, and Substance Use Involvement Test (ASSIST). Participants may also endorse alcohol use in conjunction with substance use as indicated by an Alcohol Use Disorder Identification Test-Concise (AUDIT-C) score of Moderate Risk.

Disqualifiers

A priori participant request for participation

Previously enrolled in this or other study of substance use disorder prevention

Language other than English

Expected/actual ED disposition of hospitalization or non-independent status

Trial design

Design model

Parallel

Treatments tested in this trial

  • ED-SMART intervention

    Behavioral

    The ED-SMART intervention will include: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals

  • Substance use information

    Behavioral

    The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Research staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up.

Treatment groups

650 Participants
are divided into 2 treatment groups
Group A: ED-SMART interventionExperimental treatment 1 intervention
Group B: Substance use informationPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Self-reported substance use

Self-reported substance use frequency

Time frame
From baseline to the sixth month follow-up assessment

Secondary outcomes

1

Self-reported substance use quantity

Self-reported substance use quantity for each substance

Time frame
From baseline to the six month follow-up
2

Incidence of positive substance use disorder screen

Incidence of positive substance use disorder screen as measured by the NIDA Modified ASSIST or AUDIT

Time frame
From baseline to the six month follow-up
3

Toxicology assays for substance use

Proportion with positive toxicology assay for substance use

Time frame
From baseline to the six month follow-up assessment
4

Self-reported healthcare utilization

Self-reported healthcare utilization

Time frame
Baseline to the six month follow-up assessment

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Purdue University

Lead sponsor

Centers for Disease Control and Prevention

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: